| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,044,492 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Elrifi Ivor | Chief Executive Officer | 3 | $985,909 | 0 | $0 | $985,909 |
| CERRONE GABRIELE M | 2 | $58,583 | 0 | $0 | $58,583 |
Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing …
Over the last 12 months, insiders at Tiziana Life Sciences Ltd have bought $1.04M and sold $0 worth of Tiziana Life Sciences Ltd stock.
On average, over the past 5 years, insiders at Tiziana Life Sciences Ltd have bought $1.04M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Elrifi Ivor (Chief Executive Officer) — $985,909. CERRONE GABRIELE M () — $58,583.
The last purchase of 237,616 shares for transaction amount of $237,616 was made by Elrifi Ivor (Chief Executive Officer) on 2026‑08‑05.
| 2026-08-05 | Elrifi Ivor | Chief Executive Officer | 237,616 0.3772% | $1.00 | $237,616 | +2.02% | ||
| 2026-08-04 | Elrifi Ivor | Chief Executive Officer | 83,807 0.132% | $0.97 | $81,293 | +4.38% | ||
| 2026-08-03 | Elrifi Ivor | Chief Executive Officer | 667,000 1.1571% | $1.00 | $667,000 | +4.20% | ||
| 2026-07-21 | CERRONE GABRIELE M | 42,357 0.0659% | $0.99 | $41,933 | 0.00% | |||
| 2026-06-12 | CERRONE GABRIELE M | 15,000 0.0255% | $1.11 | $16,650 | -6.36% |
| Increased Positions | 13 | +35.14% | 362,861 | +8.93% |
| Decreased Positions | 12 | -32.43% | 1M | -36.72% |
| New Positions | 7 | New | 162,687 | New |
| Sold Out Positions | 6 | Sold Out | 211,752 | Sold Out |
| Total Postitions | 38 | +2.7% | 3M | -27.8% |